Free Trial
NASDAQ:ATHX

Athersys (ATHX) Stock Price, News & Analysis

Athersys logo

About Athersys Stock (NASDAQ:ATHX)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
5,040 shs
Average Volume
1.77 million shs
Market Capitalization
$833,000.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product includes MultiStem cell therapy, an allogeneic stem cell product for the treatment of patients suffering from neurological damage from an ischemic stroke, as well as for acute respiratory distress syndrome, trauma complications, HSC transplant support, and other indications. It also develops MultiStem cell therapy to promote tissue repair and healing for animal patients. The company has license and collaboration agreements with Healios K.K. to develop and commercialize MultiStem cell therapy for ischemic stroke, acute respiratory distress syndrome, and ophthalmological indications, as well as for the treatment of liver, kidney, pancreas, and intestinal tissue diseases; and the University of Minnesota to develop MultiStem cell therapy platform. The company was founded in 1995 and is headquartered in Cleveland, Ohio.

Receive ATHX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Athersys and its competitors with MarketBeat's FREE daily newsletter.

ATHX Stock News Headlines

Athersys, Inc. (ATHXQ)
Collect $7k per month from Tesla’s SECRET dividend
I just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend. It’s a legal income shortcut tied to Tesla and other tech giants. This backdoor is already live—and it could change the way you earn.
Toughbuilt Industries Inc (TBLT)
Athersys Inc ATHXQ
Athersys to Sell Most Assets to Healios
See More Headlines

ATHX Stock Analysis - Frequently Asked Questions

Athersys, Inc. (NASDAQ:ATHX) released its quarterly earnings data on Monday, November, 15th. The biopharmaceutical company reported ($1.75) earnings per share for the quarter, topping analysts' consensus estimates of ($2.00) by $0.25. The biopharmaceutical company had revenue of $4.79 million for the quarter.

Shares of Athersys reverse split before market open on Monday, August 29th 2022. The 1-25 reverse split was announced on Monday, August 29th 2022. The number of shares owned by shareholders was adjusted after the market closes on Monday, August 29th 2022. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

Shares of ATHX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Athersys investors own include Bank of America (BAC), Predictive Oncology (POAI), Ford Motor (F), Agenus (AGEN), JPMorgan Chase & Co. (JPM), Wells Fargo & Company (WFC) and Abbott Laboratories (ABT).

Company Calendar

Last Earnings
11/15/2021
Today
6/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:ATHX
Employees
24
Year Founded
1995

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$72.53 million
Pretax Margin
-46,304.93%

Debt

Sales & Book Value

Annual Sales
$146,000.00
Price / Cash Flow
N/A
Book Value
($1.33) per share
Price / Book
N/A

Miscellaneous

Free Float
61,700,000
Market Cap
$833,000.00
Optionable
No Data
Beta
-0.90

Social Links

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NASDAQ:ATHX) was last updated on 6/5/2025 by MarketBeat.com Staff
From Our Partners